Janux Therapeutics Inc (JANX)

Cash & Equivalents

$27.77M

Quarterly · Period ending: · USD

JANX logo

JANX Cash & Equivalents

Latest reported$52.33M
JANX FY Cash & Equivalents ($658.00K → $52.33M)
High-resolution chart · PNG

JANX cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
52,334,000
430,605,000
19,205,000
51,426,000
35,582,000
7,813,000
658,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.